View allAll Photos Tagged bioinformatics
Students in the biology class, Genomics and Bioinformatics, confer with professor Mathew Jones Rhoades, as they prepare their final projects in the Scripps Landstrum Laboratory at Knox College. Photo by Peter Bailley.
www.sk.ru/en Boston, USA 18JUN2012
Representatives from the Skolkovo Foundation participated in the 2012 BIO International Convention at the Boston Convention and Exhibition Center June 18-21. The conference, attended by pharmaceutical companies, teaching hospitals, venture capital firms and over 500 biotechnology companies, drew more than 15,000 attendees to the Boston area.
www.sk.ru/en Boston, USA 18JUN2012
Representatives from the Skolkovo Foundation participated in the 2012 BIO International Convention at the Boston Convention and Exhibition Center June 18-21. The conference, attended by pharmaceutical companies, teaching hospitals, venture capital firms and over 500 biotechnology companies, drew more than 15,000 attendees to the Boston area.
Chir-Ren Shyu presented awards for the bioinformatics and computation biology category at the awards ceremony for poster session winners during Missouri Life Sciences Week 2019. | photo by Danielle Pycior, Bond LSC
www.sk.ru/en Boston, USA 18JUN2012
Representatives from the Skolkovo Foundation participated in the 2012 BIO International Convention at the Boston Convention and Exhibition Center June 18-21. The conference, attended by pharmaceutical companies, teaching hospitals, venture capital firms and over 500 biotechnology companies, drew more than 15,000 attendees to the Boston area.
Ophiux (2016)
For her upcoming touring exhibition at Sonic Acts - against the backdrop of the emergent field of computational biology and the Google Genomics project - she invented Ophiux, a speculative pharmaceutical company, imagining its use of genetic sequencing equipment and biological machines to collect data from humans and to sample data from other organisms. Holder explains: ‘It seems as if everything has become a branch of computer science, even our own bodies probed, imaged, modelled and mapped: re-drawn as digital information’.
Ophiux was originally commissioned by Wysing Arts Centre, Cambridge, with funding from Arts Council England in 2016. The film was co-commissioned with Deptford X, London. With thanks to Dr Marco Galardini, Computational Biologist at the European Bioinformatics Institute at the Wellcome Trust Genome Campus, Cambridge, Dr Katrin Linse, Senior Biodiversity Biologist at the British Antarctic Survey, Cambridge, Alex Walker, Graphic Designer and AJA, Sound Design.
Figure 6A (colour inverted) from The Roles of β²-Tubulin Mutations and Isotype Expression in Acquired Drug Resistance Published in Cancer Informatics
At the end of the GLBRC RET program, participants give presentations at a mini-symposium sharing their research experience and demonstrating one of the classroom activities they developed. Lisa shares her sequence of lessons in which students will use online bioinformatic tools to ID a new species of yeast found in Wisconsin.
Figure 3 from Functional Evolution of BRCT Domains from Binding DNA to Protein Published in Evolutionary Bioinformatics
Photo showing from left to right: Barbara Hohn (AT/CH) (a biochemist at the Friedrich Miescher Institute in Basel), Charlotte Jarvis (UK) (currently artist in residence at The Netherlands Proteomics Centre), Nick Goldman (UK) (European Bioinformatics Institute in Hinxton (UK)) and Michael Doser (AT/CH).
at "the TOTAL RECALL – Symposium – Panel 2".
credit: tom mesic
In professor Michelle Arbeitman's lab, post-doctoral fellows Matt Lebo (right, Ph.D. in Computational Biology and Bioinformatics '08) and Saori Lobbia analyze DNA gel electrophoresis data with Thomas Goldman (left), a Ph.D. candidate in molecular biology. Photo by: Philip Channing
Steven Jones, a pioneering bioinformatics expert at SFU and the B.C. Cancer Agency's Genome Sciences Centre, has been inducted into the Canadian Academy of Health Sciences.
Jones, the associate director and head of bioinformatics at the B.C. Cancer Agency's Genome Sciences Centre, also co-discovered a breakthrough in cancer causes and survival rates.
Overview of the abyss-pe makefile.
Abyss is a denovo genome assembler, that is it takes the fragmented, short read information from genome sequencing runs and assembles them into long stretches of continuous sequence, or contigs.
There may be things I have got slightly wrong in the annotation and corrections are always welcome.
Made using gvmake, from the Makefile::GraphViz perl module on CPAN.
Questi sono alcuni dei panelli dove venivano attaccati i poster (erano almeno il doppio di quelli inquadrati)
The "quick reference" Poster available here from the Research Collaboratory for Structural Bioinformatics (RCSB)
Photo showing from left to right: Barbara Hohn (AT/CH) (a biochemist at the Friedrich Miescher Institute in Basel), Charlotte Jarvis (UK) (currently artist in residence at The Netherlands Proteomics Centre), Nick Goldman (UK) (European Bioinformatics Institute in Hinxton (UK)) and Michael Doser (AT/CH).
at "the TOTAL RECALL – Symposium – Panel 2".
credit: tom mesic
CAREG stands for "The Center for Advanced Research in Environmental Genomics". In French, it's CRAGE, which is "Le Centre de Recherche Avancée en Génomique Environnementale".
Here's an explanation of what they do from the CAREG homepage.
"The central goal of CAREG is to study the effects of environmental stressors on genome function and expression. The members of CAREG are united by a common interest in understanding the variations that take place at the molecular, genetic, physiological and ecological levels and how these variations affect an organism's response to an environmental stressor. To determine the relationships between variations taking place at the different levels constitutes another common goal of the CAREG team. To achieve our objectives, we are applying the power of modern genomics research to problems of environmental biology – environmental genomics. We also look at the interactions between environmental heterogeneity and genetic variation in a number of microbes, plants and animals, including humans. The powerful tools of genomics, proteomics and bioinformatics research provide us with novel approaches to solve problems of environmental biology."
I guess that means that they are looking at micro-evolutionary "adaptation" on the cellular and genetic scale as changes to the environment changes local ecosystems and whatnot.
Note the greenhouse on the roof.
Taken from the window of the OC Transpo 95 Orléans bus as it passed by the Campus Transitway stop.
Database relationship graph for San Francisco Botanical Gardens specimen database showing tables and relationships.
www.sk.ru/en Boston, USA 18JUN2012
Representatives from the Skolkovo Foundation participated in the 2012 BIO International Convention at the Boston Convention and Exhibition Center June 18-21. The conference, attended by pharmaceutical companies, teaching hospitals, venture capital firms and over 500 biotechnology companies, drew more than 15,000 attendees to the Boston area.
www.statnews.com/2022/12/21/screening-asymptomatic-patien...
Infectious disease board recommends hospitals stop screening asymptomatic patients for Covid-19
www.msn.com/en-us/health/other/italy-says-covid-cases-on-...
Italy Says Covid Cases on China Arrivals Are Omicron
(Bloomberg) -- Italy didn’t find any new concerning Covid-19 mutations among recent arrivals from China who tested positive for the virus, a relief for officials worried about fresh health threats.
Prime Minister Giorgia Meloni said Italy already sequenced half of the samples tested in Milan and they all show the omicron strain of the coronavirus.
“This is quite reassuring,” she said at a press conference Thursday. “The situation in Italy is under control, and there are no immediate concerns.”
Italy sequenced the viral samples of passengers on two recent flights from China. About half of those on the planes had tested positive, though most weren’t showing symptoms.
In Germany, the health ministry said it’s seen no evidence of a variant of concern emerging in China compared to what’s already circulating in Germany.
www.msn.com/en-us/money/other/china-s-covid-outbreak-driv...
China’s Covid Outbreak Driven by Existing Strains, Global Consortium Finds
(Bloomberg) -- The Covid-19 outbreak that’s hitting China is being caused by strains of the virus that have already circled the world, with no signs yet of significant new mutations emerging, according to officials at a global consortium that’s tracking the pandemic.
Chinese authorities submitted 25 new genetic samples from Beijing, Inner Mongolia and Guangzhou taken in the past month to GISAID, a database where scientists from around the world share coronavirus sequences as a way to monitor mutations. Tiny changes, which occur naturally as the virus passes from one person to another, have allowed scientists to track how the pathogen has moved in China and provide reassurance about its direction thus far.
“There is no evidence at this point to suggest there is any new variant of any significance,” Peter Bogner, chief executive officer of GISAID, said in a telephone interview.
The details gathered from the genetic samples are a snapshot of the current situation in China, said Sebastian Maurer-Stroh, chief scientist at GISAID’s global data science center in Singapore. It hasn’t been brewing its own independent variant, but instead imported strains are circulating, he said.
Variant Worries
Some global health authorities and governments have expressed concern the outbreak in China, which may be experiencing as many as 37 million new infections a day, could spur the development of dangerous new variants that would once again sweep across the world. It’s unclear how the virus will act next in China, given that its earlier no-tolerance approach and reliance on inactivated vaccines have created a very different immunity landscape.
The samples submitted by the Chinese Centers for Disease Control and Prevention closely resemble existing strains found among GISAID’s 14.4 million Covid genomes, the officials said. The closest related genomes, to subvariants of omicron known as BF.7 and BA.5.2, were collected in the US and Russia this summer.
There were several independent imports of infection among the cases in Guangzhou, made up of the earlier BA.5.2 omicron subvariant, Maurer-Stroh said. The Inner Mongolia outbreak stemmed from the more recent BF.7 variant, and spread from there to Beijing, the data show.
China has been working closely with GISAID as the outbreak flared up. That relationship should help inform the world if any worrisome mutations do emerge, the officials said.
“We have no idea where this virus may go,” said Maurer-Stroh, who is also executive director of the Bioinformatics Institute at Singapore’s Agency for Science, Technology and Research. “Right now the snapshot doesn’t give away anything. The rest is speculation.”
www.msn.com/en-us/health/other/china-s-covid-19-surge-rai...
China's COVID-19 surge raises odds of new coronavirus mutant
Could the COVID-19 surge in China unleash a new coronavirus mutant on the world?
Scientists don’t know but worry that might happen. It could be similar to omicron variants circulating there now. It could be a combination of strains. Or something entirely different, they say.
“China has a population that is very large and there’s limited immunity. And that seems to be the setting in which we may see an explosion of a new variant," said Dr. Stuart Campbell Ray, an infectious disease expert at Johns Hopkins University.
Every new infection offers a chance for the coronavirus to mutate, and the virus is spreading rapidly in China. The country of 1.4 billion has largely abandoned its “zero COVID” policy. Though overall reported vaccination rates are high, booster levels are lower, especially among older people. Domestic vaccines have proven less effective against serious infection than Western-made messenger RNA versions. Many were given more than a year ago, meaning immunity has waned.
The result? Fertile ground for the virus to change.
“When we’ve seen big waves of infection, it’s often followed by new variants being generated,” Ray said.
About three years ago, the original version of the coronavirus spread from China to the rest of the world and was eventually replaced by the delta variant, then omicron and its descendants, which continue plaguing the world today.
Dr. Shan-Lu Liu, who studies viruses at Ohio State University, said many existing omicron variants have been detected in China, including BF.7, which is extremely adept at evading immunity and is believed to be driving the current surge.
Experts said a partially immune population like China’s puts particular pressure on the virus to change. Ray compared the virus to a boxer that “learns to evade the skills that you have and adapt to get around those.”
One big unknown is whether a new variant will cause more severe disease. Experts say there’s no inherent biological reason the virus has to become milder over time.
“Much of the mildness we’ve experienced over the past six to 12 months in many parts of the world has been due to accumulated immunity either through vaccination or infection, not because the virus has changed" in severity, Ray said.
In China, most people have never been exposed to the coronavirus. China's vaccines rely on an older technology producing fewer antibodies than messenger RNA vaccines.
Given those realities, Dr. Gagandeep Kang, who studies viruses at the Christian Medical College in Vellore, India, said it remains to be seen if the virus will follow the same pattern of evolution in China as it has in the rest of the world after vaccines came out. “Or," she asked, “will the pattern of evolution be completely different?”
Recently, the World Health Organization expressed concern about reports of severe disease in China. Around the cities of Baoding and Langfang outside Beijing, hospitals have run out of intensive care beds and staff as severe cases surge.
China’s plan to track the virus centers around three city hospitals in each province, where samples will be collected from walk-in patients who are very sick and all those who die every week, Xu Wenbo of the Chinese Center for Disease Control and Prevention said at a briefing Tuesday.
He said 50 of the 130 omicron versions detected in China had resulted in outbreaks. The country is creating a national genetic database “to monitor in real time” how different strains were evolving and the potential implications for public health, he said.
At this point, however, there’s limited information about genetic viral sequencing coming out of China, said Jeremy Luban, a virologist at the University of Massachusetts Medical School.
“We don’t know all of what’s going on,” Luban said. But clearly, "the pandemic is not over.”
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
www.msn.com/en-in/health/healthy-lifestyle/amid-china-cov...
Amid China Covid surge, is BF.7 variant of Omicron a threat to India? Experts say ‘no need to panic’
Can BF.7 variant cause destruction in India?
The BF.7 strain, which is a sub-lineage of the Omicron variant of Covid-19, is highly transmissible and one person can infect up to 18 people, according to experts. It has similar symptoms to other Covid variants, such as cough, fever, cold, body aches and breathing issues.
While the BF.7 variant has caused major destruction in China, the experts in India believe that if proper precaution is exercised, there is “no need to panic” when it comes to the spread of this highly transmissible Omicron strain.
The introductory workshop in bioinformatics and genomics held at ILRI, Nairobi 24-28 February 2014, was conducted by BecA-ILRI Hub in collaboration with the National Science Foundation, the Fulbright Foundation, and Reed and Lewis & Clark Colleges. The workshop was facilitated by Prof Sarah Schaack, Assistant Professor of Biology, Reed College, USA . (photo credit: BecA-ILRI Hub/Ethel Makila)
This is my first scientific poster. Please criticise my scientific poster. I really need some inputs. Thanks.
My main problem is actually the size limit. I take out the bioinformatic analysis, which include the theoretical modelling of the protein and the sequence alignment. :)
An overview of how the abyss-pe makefile assembles a genome. Hope this helps some other people when using the ABYSS assembler. Annotated version here: <a www.flickr.com/photos/robsyme/3815704409/
Most of the steps (from 'name-3.fa' down) are dedicated to using the paired end read data.
Made using gvmake, from Makefile::GraphViz on CPAN.
Participants in the Advanced Bioinformatics annual training workshop conducted by BecA-ILRI Hub in collaboration with the Swedish University of Agriculture Sciences (SLU) in Nairobi, Kenya October 7th - 18th, 2013
Photo credit: BecA-ILRI/Tim Hall
Bryn Williams-Jones of Connected Discovery Ltd: "SME's form a huge percentage of the end-users of bioinformatics resources. I'm here to talk about what they need the data for, and how they need the services to evolve. I'm also very interested to learn about how biotech works in Italy. There are a lot of people doing very valuable work here, but they need to talk about it more widely."
Figure 2 from Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1) Published in Bioinformatics and Biology Insights
Participants in the Advanced Bioinformatics annual training workshop conducted by BecA-ILRI Hub in collaboration with the Swedish University of Agriculture Sciences (SLU) in Nairobi, Kenya October 7th - 18th, 2013
Photo credit: BecA-ILRI/Tim Hall
Trīs no šīm grāmatām ir manis pirktās. Lai arī mani tas daļēji ir iedzinis bankrotā, grāmatas šeit maksā daudz lētāk nekā jebkurā veikalā, kas būtu pieejams Eiropā vai Amerikā.
Introduction to Algorithms - 40 USD, Amazonē - 82 USD.
Bioinformatics - 35 USD, Amazonē 49 USD.
Natural Language Processing - 35 USD, Amazonē - 63 USD.
Pagājušosemestr bija Artificial Intelligence - 35 USD, Amazonē - 115 USD.
Test of an art concept for an institutional fundraiser. The sharp-eyed and bored among you may recognize six of my previous photos in this mess.
The original composition was about the size of the "blackboard" in the centre. When I increased the canvas size to add a gray border, parts of the other layers magically appeared. Totally unintentional.
All feedback gratefully received. I tried brightening it, and increasing the contrast and colour, but it lost something in that process. So this is the working version, for now.
Best viewed large on black.